Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02741570 |
|---|---|
| Brief Title: | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (CheckMate 651) |
| First Submitted : | April 13, 2016 |
| First Submitted that Met QC Criteria : | April 14, 2016 |
| First Posted : | April 18, 2016 (Estimate) |
| Results First Submitted : | April 6, 2022 |
| Results First Submitted that Met QC Criteria : | April 6, 2022 |
| Results First Posted : | May 3, 2022 |
| Last Update Submitted that Met QC Criteria : | October 19, 2022 |
| Last Update Posted : | October 20, 2022 |